30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Marizyme Inc (MRZM)

Track

Stock chart
Ticker: MRZM Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
MOORE JOHN A JR
1 purchase — total 35,000 USD
Buy 16 Oct 2013
Value US$1,728,476.44 | Price 333.85 | Shares 1,846
Buy 28 Feb 2013
Value US$2,671,874.57 | Price 361.42 | Shares 60,816
Buy 8 Mar 2012
Value US$8,250.00 | Price 1.65 | Shares 5,000
Buy 8 Mar 2012
Value US$16,000.00 | Price 1.60 | Shares 10,000
Buy 8 Mar 2012
Value US$13,500.00 | Price 1.50 | Shares 9,000
Buy 8 Mar 2012
Value US$1,400.00 | Price 1.40 | Shares 1,000
Buy 11 Oct 2011
Value US$15,845.44 | Price 1.69 | Shares 9,350
Buy 11 Oct 2011
Value US$15,845.44 | Price 1.69 | Shares 9,350
Buy 7 Oct 2011
Value US$6,365.00 | Price 1.90 | Shares 3,350
Buy 7 Oct 2011
Value US$8,835.00 | Price 1.90 | Shares 4,650
Sale 26 Sep 2011
Value US$1,631.00 | Price 2.33 | Shares 700
Sale 16 Sep 2011
Value US$4,300.00 | Price 2.15 | Shares 2,000
Sale 14 Sep 2011
Value US$24,672.00 | Price 2.06 | Shares 12,000
Sale 14 Sep 2011
Value US$18,504.00 | Price 2.06 | Shares 9,000
Sale 12 Sep 2011
Value US$7,500.00 | Price 2.50 | Shares 3,000
Sale 21 Sep 2009
Value US$82,500.00 | Price 0.33 | Shares 250,000
Sale 21 Sep 2009
Value US$664,560.00 | Price 0.12 | Shares 5,538,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2013-11-01 2013-10-16 B Purchase
MOORE JOHN A JR
Non-Executive Director
1,846 -4.1%
333.85
US$1,728,476 		1,846 -4.1% 333.85 US$1,728,476
2013-03-05 2013-02-28 B Purchase
MOORE JOHN A JR
Non-Executive Director
60,816 -12.0%
361.42
US$2,671,875 		60,816 -12.0% 361.42 US$2,671,875
2012-03-08 2012-03-08 B Purchase
BAKSA STEPHEN D
Non-Executive Director
11,463 -5.3%
57.66
US$3,865,243 		11,463 -5.3% 57.66 US$3,865,243
2012-03-08 2012-03-08 B Purchase
BAKSA STEPHEN D
Non-Executive Director
10,000 +0.7%
1.60
US$16,000 		10,000 +0.7% 1.60 US$16,000
2012-03-08 2012-03-08 B Purchase
BAKSA STEPHEN D
Non-Executive Director
9,000 +0.6%
1.50
US$13,500 		9,000 +0.6% 1.50 US$13,500
2012-03-08 2012-03-08 B Purchase
BAKSA STEPHEN D
Non-Executive Director
1,000 +0.1%
1.40
US$1,400 		1,000 +0.1% 1.40 US$1,400
2011-10-13 2011-10-11 B Purchase Durst Mark William
9,350 +2.8%
1.69
US$15,845 		9,350 +2.8% 1.69 US$15,845
2011-10-13 2011-10-11 B Purchase Durst John Paul
9,350 +2.8%
1.69
US$15,845 		9,350 +2.8% 1.69 US$15,845
2011-10-11 2011-10-07 B Purchase Durst Mark William
3,350 +1.0%
1.90
US$6,365 		3,350 +1.0% 1.90 US$6,365
2011-10-11 2011-10-07 B Purchase Durst John Paul
4,650 +1.4%
1.90
US$8,835 		4,650 +1.4% 1.90 US$8,835
2011-09-28 2011-09-26 S Sale Durst Mark William
700 -0.2%
2.33
US$1,631 		700 -0.2% 2.33 US$1,631
2011-09-20 2011-09-16 S Sale Durst John Paul
2,000 -0.6%
2.15
US$4,300 		2,000 -0.6% 2.15 US$4,300
2011-09-16 2011-09-14 S Sale Durst John Paul
12,000 -3.5%
2.06
US$24,672 		12,000 -3.5% 2.06 US$24,672
2011-09-16 2011-09-14 S Sale Durst Mark William
9,000 -2.7%
2.06
US$18,504 		9,000 -2.7% 2.06 US$18,504
2011-09-14 2011-09-12 S Sale Durst Mark William
3,000 -0.9%
2.50
US$7,500 		3,000 -0.9% 2.50 US$7,500
2009-09-29 2009-09-21 S Sale Fung Vanleo Y.W.

former director & officer
250,000 -71.4%
0.33
US$82,500 		250,000 -71.4% 0.33 US$82,500
2009-09-23 2009-09-21 S Sale
LAM PUI SHAN

former director officer owner
5,538,000 -92.3%
0.12
US$664,560 		5,538,000 -92.3% 0.12 US$664,560
Explore more

More insider trading research around Marizyme Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America